.svg){kind=small}
We are using conventional paper CRFs (so there is no worry for clients) which are then remotely entered into a database enabling us to produce tables and listings for safety review within two days of dosing. This is particularly useful in dose escalation studies as meaningful safety reviews can be developed within a very effective time frame.
.avif)
Latest news
Richmond Pharmacology Welcomes Back Dr Edward Jackson as Medical Director
November 3, 2025
Richmond Pharmacology is pleased to announce the return of Dr Edward Jackson, who re-joins the organisation as Medical Director.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
